Table 2 The patients’ clinicopathological parameters and comparisons of them between the two groups
Clinicopathological parameters | Group A (HLNs <22; N = 157), n (%) | Group B (HLNs ≥22; N = 242), n (%) | P-value |
|---|---|---|---|
Sex | 0.504 | ||
Male | 110 (70.1) | 177 (73.1) | |
Female | 47 (29.9) | 65 (26.9) | |
Age | 0.108 | ||
≤60 | 89 (56.7) | 147 (60.7) | |
>60 | 68 (43.3) | 95 (39.3) | |
BMI | 0.732 | ||
<19 | 13 (8.4) | 18 (7.7) | |
~ < 25 | 93 (60.4) | 154 (65.5) | |
~ < 30 | 43 (27.9) | 58 (24.7) | |
≥30 | 5 (3.2) | 5 (2.1) | |
NACT | 0.392 | ||
No | 114 (72.6) | 166 (68.6) | |
Yes | 43 (27.4) | 76 (31.4) | |
Differentiation | 0.003 | ||
Well | 12 (8.5) | 11 (4.8) | |
Moderate | 90 (63.4) | 113 (49.8) | |
Poor | 40 (28.2) | 103 (45.4) | |
LVI | 0.834 | ||
No | 139 (88.5) | 213 (88.0) | |
Yes | 18 (11.5) | 29 (12.0) | |
Tumour size | <0.001 | ||
≤5 cm | 146 (95.4) | 196 (83.4) | |
>5 cm | 7 (4.6) | 39 (16.6) | |
Gastrectomy | <0.001 | ||
Distal | 84 (54.2) | 145 (59.9) | |
Proximal | 48 (31.0) | 23 (9.5) | |
Total | 23 (14.8) | 74 (30.6) | |
T stagea | 0.003 | ||
T1 | 65 (43.6) | 64 (27.6) | |
T2 | 37 (24.8) | 53 (22.8) | |
T3 | 1 (0.7) | 2 (0.9) | |
T4 | 46 (30.9) | 113 (48.7) |